Iovance Biotherapeutics Inc. buy Barclays PLC
Start price
29.02.24
/
50%
€15.05
Target price
28.02.25
€20.28
Performance (%)
-73.24%
End price
01.03.25
€4.03
Summary
This prediction ended on 01.03.25 with a price of €4.03. The BUY prediction by Barclays_PLC for Iovance Biotherapeutics Inc. performed very badly with a performance of -73.24%. Barclays_PLC has a follow-up prediction for Iovance Biotherapeutics Inc. where he still thinks Iovance Biotherapeutics Inc. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Iovance Biotherapeutics Inc. | 10.798% | 10.798% | -79.040% |
| iShares Core DAX® | -0.727% | 2.783% | 28.954% |
| iShares Nasdaq 100 | 1.839% | 5.294% | 5.747% |
| iShares Nikkei 225® | -2.033% | -0.196% | -4.367% |
| iShares S&P 500 | 1.334% | 4.044% | 5.224% |
Comments by Barclays_PLC for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target raised by analysts at Barclays PLC from $18.00 to $22.00. They now have an "overweight" rating on the stock.
Ratings data for IOVA provided by MarketBeat
In the thread Trading Iovance Biotherapeutics Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€3.00
14.04.25
14.04.25
€4.39
14.04.26
14.04.26
-44.37%
15.07.25
15.07.25
Stopped prediction by Barclays_PLC for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.63
12.05.25
12.05.25
€3.56
12.05.26
12.05.26
2.12%
15.07.25
15.07.25